📰 Human Use News
Page 88 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
February 23, 2023
/PRNewswire/ -- Akebia Therapeutics®, Inc. (NASDAQ: AKBA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
February 22, 2023
HRMY earnings call for the period ending December 31, 2022.
February 22, 2023
The tablet formulation for AZ's BTK inhibitor has gained EU approval for co-administration with gastric acid-reducing agents in leukaemia.
February 22, 2023
Boost for effected patients as HEMGENIX receives green light from European Commission - News - PharmaTimes
February 22, 2023
The European Medicines Agency (EMA) has raised significant concerns about the impurity of truncated mRNA found in Pfizer’s ...
February 21, 2023
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/
February 21, 2023
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces that the first patient has been enrolled...
February 21, 2023
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
February 21, 2023
Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA) for HEMGENIX® (etranacogene dezaparvovec), the first and only one-time gene therapy for the treatment of severe and moderately severe hemophilia B (congenital Factor IX ...
February 21, 2023
The first gene therapy for haemophilia B has been given conditional marketing authorisation in Europe by the European Commission.